A cross-sectional survey on nutritional risk and prevalence of malnutrition per Global Leadership Initiative on Malnutrition criteria in patients with end-stage malignant gastrointestinal tumors in a tertiary (A) hospital in Changsha
10.3760/cma.j.cn115822-20210601-00124
- VernacularTitle:长沙某三甲医院消化道终末期癌症住院患者营养风险、营养不良（GLIM）患病率横断面调查
- Author:
Minjie ZENG
1
;
Mengyou ZHANG
;
Ming LIU
;
Yu ZHANG
;
Huan WAN
;
Chen CHEN
;
Yanping XIE
;
Ke TANG
;
Zhan LIU
;
Liuqing YAN
;
Han GU
;
Xianna ZHANG
;
Zhuming JIANG
Author Information
1. 湖南省人民医院（湖南师范大学附属第一医院）消化营养科，长沙 410004
- Keywords:
terminal stage gastrointestinal malignant tumor;
Malnutrition
- From:
Chinese Journal of Clinical Nutrition
2021;29(5):275-280
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the nutritional risk and prevalence of malnutrition in patients with terminal stage gastrointestinal malignant tumors in a tertiary hospital in Changsha.Methods:Cluster sampling was used to conduct a cross-sectional survey of inpatients from Departments of Gastroenterology, Gastrointestinal Surgery, Hepatobiliary Surgery and Oncology in Hunan Provincial People's Hospital from January 2019 to July 2020. Nutritional Risk Screening 2002 (NRS 2002) was used to assess the prevalence of nutritional risk with malnutrition defined as concurrent presence of BMI < 18.5 kg/m 2, poor general condition and NRS 2002 nutritional impairment score of 3. Step 2 of Global Leadership Initiative on Malnutrition (GLIM) diagnostic criteria (without whole body muscle mass) was adopted to diagnose malnutrition. Step 3 of GLIM criteria was used to evaluate the prevalence of severe malnutrition. Results:A total of 802 patients registered in the 4 departments were selected for screening via cluster sampling and 514 were enrolled according to the inclusion/exclusion criteria. The prevalence of nutritional risk in patients with terminal stage gastrointestinal cancer was 49.8% (256/514). The prevalence of malnutrition and severe malnutrition per GLIM criteria were 41.6% (214/514) and 18.3% (94/514), respectively.Conclusions:Although nutritional support therapy is not recommended for patients with end-stage cancer. This paper suggests that the prevalence of nutritional risk and malnutrition in patients with end-stage gastrointestinal cancer is not as high as described in some articles.
